In addition, in ovarian cancers, they are essential for immunosuppression due to their expression of indoleamine 2,3-dioxygenase 1 (IDO1) and the inducible T cell costimulatory ligand (ICOSL) [235]. This evidence concerns the gene IDO1 and ovarian carcinoma.